CLINICAL_TRIALS
trial_result
· 2021-05-26
Clinical Trial Update: Re-treatment of Participants With Paget's Disease Using Zoledronic Acid [Phase 4]
Summary
Phase 4 trial evaluating re-treatment of Paget's disease of the bone with zoledronic acid; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Paget's Disease of the Bone | Phase 4 | Status: COMPLETED | Results posted: 2021-05-26